STAAR Surgical Co (OQ:STAA)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 25651 Atlantic Ocean Drive
LAKE FOREST CA 92630
Tel: 1-626-3037902
Website: https://www.staar.com
IR: See website
<
Key People
Thomas G. Frinzi
Chairman of the Board, President, Chief Executive Officer
Patrick F. Williams
Chief Financial Officer
Warren Foust
Chief Operating Officer
James E. Francese
Senior Vice President - Commercial Operations, North America and APAC
Robert Studholme
Senior Vice President - Operations
Keith Holliday
Chief Technology Officer
Scott D. Barnes
Chief Medical Officer
Samuel J. Gesten
Chief Legal Officer, Corporate Secretary
 
Business Overview
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company's EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
Financial Overview
For the fiscal year ended 29 December 2023, STAAR Surgical Co revenues increased 13% to $322.4M. Net income decreased 46% to $21.3M. Revenues reflect ICLs segment increase of 18% to $319.4M, China segment increase of 25% to $185.6M, Others segment increase of 3% to $81.2M. Net income was offset by General and administrative - Balancing increase of 33% to $60.2M (expense), Marketing and selling - Balancing value increase of 24% to $57.1M (expense).
Employees: 1,056 as of Dec 29, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $2,116M as of Dec 29, 2023
Annual revenue (TTM): $322.42M as of Dec 29, 2023
EBITDA (TTM): $33.53M as of Dec 29, 2023
Net annual income (TTM): $21.35M as of Dec 29, 2023
Free cash flow (TTM): -$3.59M as of Dec 29, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 48,865,875 as of Feb 21, 2024
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.